PRINCETON, N.J., Feb. 1, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Hong Kong Registrar of Patents has granted a patent for the application… Read More..

LOS ANGELES, Jan. 27, 2021 /PRNewswire/ -- PodcastOne, a leading podcast platform and a subsidiary of LiveXLive Media (NASDAQ: LIVX) ("LiveXLive"), announced today that it has finalized a deal to bring the award winning podcast "Our Fake History" into the fold by acquiring the exclusive sales and distribution rights to… Read More..

Balance Sheet Further Strengthened by Receipt of Additional $3.3 Million from Exercise of Existing Warrants Mountain View, CA, Jan. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through… Read More..